KYLO-0603, a novel liver-targeting, thyroid hormone receptor-β agonist for the inhibition of MASH progression. - lu, Xueqin; Wang, Shengjun; Du, Yanchun; Xie, Bixian; Chen, Qingyan; Lin, Jinzhen; Chen, Bailing; Cui, Kunyuan (PLoS ONE, 2025)